Peripheral Blood Mononuclear Cells, Frozen | StemExpress

Peripheral Blood Mononuclear Cells, Frozen

In stock
Category: Research & Clinical Products
Select SKU Size / Day Price
PBMNC015C 15 million/vial $129 USD
PBMNC025C 25 million/vial $204 USD
PBMNC050C 50 million/vial $296 USD
PBMNC100C 100 million/vial $444 USD
PBMNC300C 300 million/vial $842 USD
Questions about shipping? See Shipping Info
Questions? Contact Sales:
Contact Us
Product Description

Peripheral blood mononuclear cells (PBMCs) are composed of lymphocytes (T cells, B cells, and NK cells), monocytes, dendritic cells, and stem/progenitor cells. These cells are critical components of the immune system and play key roles in the humoral and cell-mediated immune responses. PBMCs are commonly used in research and clinical applications in the areas of immunology, infectious disease, hematological malignancies, vaccine development, transplant therapy, and high-throughput screening.

Peripheral blood mononuclear cells are separated from peripheral blood by apheresis. PBMCs are screened for the expression CD45 and checked for viability using flow cytometry. This highly pure population of cells makes them ideal for further isolations of specific cell types within the PBMC fraction.

Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.

More Information
Species Human
Disease State Healthy
Cell and Tissue Source Peripheral Blood
Cell Type Mononuclear Cells
Donor Attributes Inquire
Viability ≥80% by Flow Cytometry
Format Frozen
Contains CryoStor™ CS10 (10% DMSO)
Anticoagulant ACD-A
Application Area Research

Product Information Sheet

Certificate of Analysis

Material Safety Data Sheet


  • 1 Yang et al. (2016) Human Umbilical Cord-derived Mesenchymal Stem Cells Suppress Proliferation of PHA-activated Lymphocytes In Vitro by Inducing CD4+CD25highCD45RA+ Regulatory T Cell Production and Modulating Cytokine Secretion. Cell Immunol 302: 26-31. Abstract
  • 2 Yamada et al. (2014) G0S2 Inhibits the Proliferation of K562 Cells by Interacting with Nucleolin in the Cytosol. Leuk Res 38: 210-217. doi:10.1016/j.leukres.2013.10.006. Abstract
  • 3 Towobola et al. (2017) Novel Immunodeficient Rat Models Capable of Supporting the Growth of Human Tumor Xenografts. AACR 2017 Annual Meeting Poster. Poster
  • 4 Noto et al. (2018) The SRG™ Rat: A Novel SCID Rat for Humanization Studies. AACR 2018 Annual Meeting Poster. Poster
  • 5 Towobola et al. (2017) Novel Immunodeficient Rat Models Offers a Unique Platform for Drug Efficacy Studies in Human Tumor Xenografts. AACR-NCI-EORTC 2017 Annual Meeting Poster. Poster
  • 6 Ou et al. (2019) Novel Biomanufacturing Platform for Large-Scale and High-Quality Human T Cells Production. J Biol Eng 13:34. Article
  • 7 Yang et al. (2016) Human Umbilical Cord-Derived Mesenchymal Stem Cells Reversed the Suppressive Deficiency of T Regulatory Cells from Peripheral Blood of Patients with Multiple Sclerosis in a Co-Culture – a Preliminary Study. Oncotarget. 7(45): 72537-72545. Abstract
  • 8 Schillebeeckx et al. (2020) Analytical Performance of an Immunoprofiling Assay Based on RNA Models. J Mol Diagn. Article



Figure 1. Representative flow data of peripheral blood mononuclear cells enriched from whole blood.

Hi, have questions?

A StemExpress Expert is happy to help!

Got a Question?

Read our FAQs to answer your questions regarding the different types of donations, donor requirements, and our donation process.